CTRV News and Press, ContraVir Pharmaceuticals Inc.

EDISON, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral i...

Introduction: Theory Versus Reality Source Anyone who has run a clinical trial, treated a patient, started a new medical practice, etc., knows that many good ideas are just not as effective in reality as they are on paper- the difference between those ideas and well-executed plans alwa...

Gainers:  Vislink Technologies (NASDAQ: VISL ) +316% . Attis Industries (NASDAQ: ATIS ) +32% . Valeritas Holdings (NASDAQ: VLRX ) +27% . Harmonic (NASDAQ: HLIT ) +26% . Akoustis Technologies (NASDAQ: AKTS ) +21% . SMART Global Holdings (NASDAQ: SGH ) +21% . ContraVir Pharmaceuti...

ContraVir Pharmaceuticals (NASDAQ: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral infection, has closed an underwritten public offering res...

EDISON, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral i...

Avinger (NASDAQ: AVGR ) -10% . More news on: Avinger, Inc., Eldorado Resorts, Inc., Seadrill Limited, Stocks on the move, Read more ...

CTRV stock is one of the biggest biotech stocks after ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) gets a positive response from the FDA to its pre-IND meeting for developing CRV431 in NASH. Big Announcement New Jersey-based biopharmaceutical company ContraVir Pharmaceuticals, which is i...

Gainers: Axovant Gene Therapies (NASDAQ: AXGT ) +40% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +24% . India Globalization Capital (NYSEMKT: IGC ) +17% . Pintec Technology (NASDAQ: PT ) +14% . ObsEva SA (NASDAQ: OBSV ) +12% . Overstock.com (NASDAQ: OSTK ) +12% . Fuwei Films (NASDAQ...

ContraVir Pharmaceuticals (NASDAQ: CTRV ) +42%  on FDA reaction to CRV431 plans. More news on: ContraVir Pharmaceuticals, Inc., Axovant Gene Therapies Ltd., Seadrill Limited, Stocks on the move, Read more ...

ContraVir Pharmaceuticals (NASDAQ: CTRV )  announces receiving positive FDA feedback to its pre-IND meeting for developing CRV431 in NASH. More news on: ContraVir Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...